Dan Buettner, an expert on the world's 'Blue Zones', suggests that drinking a popular beverage in Ireland before noon could ...

This approval is based on results from the pivotal ICARIA-MM phase 3 study, using the China-based IsaFiRsT real-world study as bridging data. The ICARIA-MM study demonstrated Sarclisa in combination ...

Some areas of Britain are more like a Blue Zone than others - and it's not a coincidence that people living in these regions live longer.

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...

China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant: Paris Saturday, February 1, 2025, 12:00 Hrs [IST] The Nationa ...

This Central American gem is abounding in rugged terrain and rainforests. It’s the ultimate postcard destination with ...

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, ...

U.S. News Insider Tip: While Barceloneta is a must-see with its lively bars and restaurants, it can get crowded, so if you're looking for a quieter alternative, wander 20 minutes up the coast to ...

It is dosed every week for four weeks, and then every two weeks. The green light is on the back of the ICARIA-MM study, which showed that Sarclisa almost doubled the response rate to 60% from 35% ...